Feedback / Questions
IGNX001 - IgGenix
https://www.prnewswire.com/news-releases/iggenix-announces-first-patient-dosed-in-phase-1-clinical-trial-accelerate-peanut-evaluating-ignx001-in-peanut-allergy-302277256.html
Oct 16, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next